secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autonomix Medical, Inc. (AMIX)
CIK:        0001617867
Form:       8-K
Filed at:   2024-07-15T23:59:59+00:00
Accession:  0001437749-24-022711
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autonomix licenses FDA-cleared ablation technology; issues 250,000 shares to RF Innovations
--------------------------------------------------------------------------------

- Licensed intellectual property for Apex 6 Radiofrequency Generator, an FDA-cleared ablation device for peripheral nerve pain.
- Consideration is 250,000 shares of common stock; license is perpetual, non-exclusive, worldwide, and royalty-free.
- Transaction expected to close before the end of July 2024; manufacturing partner to be integrated into supply chain.
- Technology supports Autonomix's development for pancreatic cancer pain and other indications, potentially simplifying regulatory pathway.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1617867/000143774924022711/0001437749-24-022711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1617867/000143774924022711/amix20240714_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-022711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer